Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neonatal hyperbilirubinemia or, as otherwise known,
jaundice of the newborn
is the most common clinical problem in the newborn period. Visible jaundice is seen in 30% to 50% of infants, and in about 10%, the hyperbilirubinemia requires treatment. The critical factor that leads to the accumulation of this yellow pigment bilirubin is the
immaturity
of the newborn's liver and its inability to excrete the natural form of unconjugated bilirubin. In the past two decades phototherapy has become the routine both for treatment of neonates with hyperbilirubinemia and for prophylaxis in highrisk patients such as preterm infants. Recent information about the mechanism of phototherapy and the availability of new types of light sources prompted this review.
...
PMID:Phototherapy--1988. A green light for a new approach? 265 96
This paper presents a study of adolescent pregnancy in which different age groups were compared to establish which age group had the greatest incidence of risk factors. Primiparous adolescents who delivered at the Obstetric Clinic of the Medical School of the University of Sao Paulo, Brazil, between January 1975 and June 1980 were studied. During this period, 13,961 births occurred, of which 105 were to 9-15 year olds (0.7%), 137 were to 16 year olds (0.9%) and 106 were to 17 year olds (0.7%). A large majority of the adolescents in each age group were unmarried; similarly, a lack of adequate prenatal care was observed in all 3 groups. A gestational age of less than 38 weeks was encountered in 30.5% (30 cases), and 16.9% (18 cases), respectively, in the 9-15, 16, and 17 year age groups. Among pregnancy complications, there was an elevated incidence of arterial hypertension in all 3 groups, as well as an increased occurrence of eclampsia among the 9-15 year olds. Urinary infections and anemia were also evident during pregnancy. Analgesia was required in 22 cases (20.9%) of the 9-15 year old age group, in 3 cases (2.2%) of the 16 year age group, and in 2 cases (1.9%) of the 17 year age group. Fetal presentation, duration of labor, type of birth (normal, forceps, or cesarean), puerperal morbidity, birth weight, and perinatal mortality for each of the 3 groups are presented in tables. Neonatal deaths were determined to be the consequence of prematurity and its complications except in 1 case of congenital heart disease which occurred in the 17 year old group.
Neonatal jaundice
was the most frequent cause of morbidity in the newborns. The results of this study agree with those of similar studies appearing in the literature. The authors attribute the greater frequency of premature births among 9-16 year olds to immaturtity of uterine muscle fiber, deficient prenatal care, and the emotional tensions to which the adolescents were subjected, as well as to medical complications of pregnancy and general maternal physical
immaturity
. The 17 year olds presented behavior closer to that of the adult population.
...
PMID:[Pregnancy in the adolescent. II. Comparative study between primigravida from 9 to 15, 16 and 17 years old]. 1226 72
Late preterm gestation is an important risk factor for the development of severe neonatal hyperbilirubinemia and kernicterus. An exaggerated hepatic
immaturity
contributes to the greater prevalence, severity, and duration of
neonatal jaundice
in late preterm infants. Breast milk feeding is almost uniformly present and large for gestational age status, male sex, and G6PD deficiency are over-represented among that cohort of late preterm infants with kernicterus. Attention to screening measures for jaundice in the newborn nursery, the provision of lactation support, parental education, timely postdischarge follow-up, and appropriate treatment when clinically indicated should help to reduce the risk of late preterm neonates developing severe
neonatal jaundice
or kernicterus.
...
PMID:Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. 1714 8
The aetiopathogenesis of icterus is briefly examined and stress is laid on the
immaturity
of the neonatal and particularly of the immature infanti liver. A limit is then set between paraphysiological and serious icterus and the symptoms of neonatal hyperbilirubinaemia with or without nuclear icterus are recalled. Attention is drawn to the debated problem of the bilirubin threshold value and the different and often conflicting views of the various schools are cited. Caution is urged since the nervous damage must be evaluated even over periods of years. The techniques employed in the determination of bilirubin values are then discussed and the associated difficulty of settling the threshold level is noted; standardisation of methods is to be hoped for and reference is made to personal experience of considerable differences between venous and capillary blood when the latter is expressed. Treatment of the disease has been attempted with various substances, some (cortisones, albumin) with notable others (triiodothyronine, polyvinylpyrrolidone) with little success; the use of anti-D sera and immunoglobulins in Rh-negative mothers as a means of prevention of
neonatal jaundice
is also noted. Personal experience (113 subjects) with phototherapy is resorted and the complete absence of short or long term damage is noted. 3 1/2 years experience with exsanguinotransfusion is also presented: 57 cases (0.7% of births; mortality rate 3.5%). In 40% of these cases bilirubin values had passed the 20 mg % threshold (max. 36%); only one patient presented early and late signs of damage.
...
PMID:[The treatment of severe neonatal icterus]. 1734 88
Hyperbilirubinemia, caused by the accumulation of unconjugated bilirubin, is one of the most common clinical diagnoses in both premature and term newborns. Owing to the fact that bilirubin is metabolized solely through glucuronidation by UDP-glucuronosyltransferase (UGT) 1A1, it is now known that
immaturity
of UGT1A1, in combination with the overproduction of bilirubin during the developmental stage, acts as a bottleneck to bilirubin elimination and predisposes the infant to high total serum bilirubin levels. Although
neonatal jaundice
is mostly benign, excessively high levels of serum bilirubin in a small percentage of newborns can cause bilirubin-induced neurologic dysfunction, potentially leading to permanent brain damage, a condition known as
kernicterus
Although a large portion of hyperbilirubinemia cases in newborns are associated with hemolytic diseases, we emphasize here the impaired ability of UGT1A1 to eliminate bilirubin that contributes to hyperbilirubinemia-induced neurotoxicity in the developmental stage. As a series of hereditary UGT1A1 mutations have been identified that are associated with UGT1A1 deficiency, new evidence has verified that delayed expression of UGT1A1 during the early stages of neonatal development is a tightly controlled event involving coordinated intrahepatic and extrahepatic regulation. This review recapitulates the progress that has been made in recent years in understanding the causes and physiopathology of severe hyperbilirubinemia, investigating molecular mechanisms underlying bilirubin-induced encephalopathy, and searching for potential therapies for treating pathologic hyperbilirubinemia. Several animal models have been developed to make it possible to examine bilirubin-induced neurotoxicity from multiple directions. Moreover, environmental factors that may alleviate or worsen the condition of hyperbilirubinemia are discussed.
...
PMID:Developmental, Genetic, Dietary, and Xenobiotic Influences on Neonatal Hyperbilirubinemia. 2828 55
Neonatal hyperbilirubinemia is the elevation of the bilirubin level in the newborns blood, which results in yellowish staining of the skin and sclera of the newborn eyes by pigment of bile. It is due to the breakdown of RBC's (which release bilirubin into the blood) and the
immaturity
of newborns liver (which cannot effectively metabolize the bilirubin and prepare it for excretion into the urine). Increased bilirubin production, reduced hepatic clearance and enhanced enterohepatic circulation are the sole causes of increased prevalence of jaundice in newborn. The science of Ayurveda is supposed to add a step in order to understand the pathophysiology of
neonatal jaundice
that have resemblance with clinical entity of kamala (jaundice) mentioned in Kashyapa Samhita. The concept of neonatal hyperbilirubinemia in Ayurveda can be understood in the context of Pittaja stanya dushti along with the physiological variations in the newborns leading to the raised level of unconjugated bilirubin. Therefore, the patho-physiology should be known by a pediatrician in Ayurveda based on the involvement of dosha, dhatu, mala and srotas. Hence, an attempt is made in this review to discuss about the hidden concept of pathology of
neonatal jaundice
described in Ayurveda. These findings to understand the concept of
neonatal jaundice
in Ayurveda add up to the Ayurvedic science that has been developed through ages.
...
PMID:A critical review on neonatal hyperbilirubinemia-an Ayurvedic perspective. 3162 7